Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · Real-Time Price · USD
0.7800
-0.0349 (-4.28%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Sangamo Therapeutics Market Cap

Sangamo Therapeutics has a market cap or net worth of $175.27 million as of April 25, 2025. Its market cap has increased by 74.40% in one year.

Market Cap
175.27M
Enterprise Value
161.72M
1-Year Change
74.40%
Ranking
Category
Stock Price
$0.78

Market Cap Chart

Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from $314.10M to $175.27M, a decrease of -44.20%. That is a compound annual growth rate of -2.30%.

History

DateMarket Cap% Change
Apr 24, 2025183.10M-13.96%
Dec 31, 2024212.80M120.98%
Dec 29, 202396.30M-81.29%
Dec 30, 2022514.60M-52.90%
Dec 31, 20211.09B-50.50%
Dec 31, 20202.21B127.45%
Dec 31, 2019970.40M-17.20%
Dec 31, 20181.17B-15.45%
Dec 29, 20171.39B543.50%
Dec 30, 2016215.40M-66.32%
Dec 31, 2015639.50M-38.53%
Dec 31, 20141.04B21.20%
Dec 31, 2013858.40M169.51%
Dec 31, 2012318.50M113.76%
Dec 30, 2011149.00M-50.38%
Dec 31, 2010300.30M12.98%
Dec 31, 2009265.80M86.40%
Dec 31, 2008142.60M-72.71%
Dec 31, 2007522.60M133.30%
Dec 29, 2006224.00M118.75%
Dec 30, 2005102.40M-32.23%
Dec 31, 2004151.10M11.35%
Dec 31, 2003135.70M83.13%
Dec 31, 200274.10M-67.54%
Dec 31, 2001228.30M-47.02%
View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 772.03B
UnitedHealth Group 386.16B
Johnson & Johnson 372.77B
AbbVie 319.07B
Novo Nordisk 276.96B
Abbott Laboratories 224.40B
AstraZeneca 215.41B
Novartis AG 210.89B
Market Cap Rankings